Breaking new ground: MASLD vs. MAFLD-which holds the key for risk stratification?
Mariana Michelle Ramírez-MejíaCarlos Jiménez-GutiérrezMohammed EslamJacob GeorgeNahum Méndez-SánchezPublished in: Hepatology international (2023)
Although MASLD has a higher capture of lean patients compared to MAFLD, patients with MAFLD and MASLD have a worse metabolic profile than those with only MASLD. Our results provide evidence that MAFLD better identifies patients likely to have a higher risk of liver fibrosis and of disease progression.